KDA
- Current
- Browse
- Collections
-
For contributors
- For Authors
- Instructions for authors
- Article processing charge
- For Reviewers
- Instructions for reviewers
- How to become a reviewer
- Best reviewers
- For Readers
- Readership
- Subscription
- Permission guidelines
- About
- Editorial policy
Articles
- Page Path
- HOME > Diabetes Metab J > Volume 32(6); 2008 > Article
- Letter The Effect of Rosiglitazone and Metformin Therapy, as an Initial Therapy, in Patients with Type 2 Diabetes Mellitus.
- Dong Lim Kim
-
Diabetes & Metabolism Journal 2008;32(6):532-533
DOI: https://doi.org/10.4093/kdj.2008.32.6.532
Published online: December 1, 2008
- 2,413 Views
- 18 Download
- 0 Crossref
- 0 Scopus
Division of Endocrinology and Metabolism, Department of Internal Medicine, Konkuk University School of Medicine, Korea.
Abstract
No abstract available.
Cite- Related articles
-
- Efficacy and Safety of Automated Insulin Delivery Systems in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
- Use of Glucagon-Like Peptide-1 Receptor Agonists Does Not Increase the Risk of Cancer in Patients with Type 2 Diabetes Mellitus
- Ideal Combination of Oral Hypoglycemic Agents for Patients with Type 2 Diabetes Mellitus
- Benefit and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
- Association of Succinate and Adenosine Nucleotide Metabolic Pathways with Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
- Kim DL. The Effect of Rosiglitazone and Metformin Therapy, as an Initial Therapy, in Patients with Type 2 Diabetes Mellitus.. Diabetes Metab J. 2008;32(6):532-533.
- DOI: https://doi.org/10.4093/kdj.2008.32.6.532.
-
- Download citation ↓
